John D Scheu

Title: Innovations by John D. Scheu in Radiolabeling Biomolecules

Introduction

John D. Scheu is an accomplished inventor based in South Bend, Indiana. He has made significant contributions to the field of biomolecular imaging through his innovative methods for radionuclide-labeling of biomolecules. His work has the potential to enhance medical imaging techniques, particularly in the context of human tissue analysis.

Latest Patents

John D. Scheu holds a patent for "Methods for radionuclide-labeling of biomolecules and kits utilizing the." This patent describes novel methods for radiolabeling sulfhydryl group-bearing biomolecules. It includes compositions useful for this purpose and kits that comprise these novel compositions. The methods are particularly useful for labeling biomolecules such as whole molecule proteins, protein fragments, or peptides, with a focus on monoclonal or polyclonal antibodies, especially the antifibrin MH1 monoclonal antibody.

Career Highlights

Scheu is associated with American Biogenetic Sciences, Inc., where he applies his expertise in biomolecular research. His work has contributed to advancements in the field, particularly in the development of imaging techniques that utilize radiolabeled biomolecules.

Collaborations

One of his notable coworkers is Paul E. Gargan. Their collaboration has likely fostered innovative approaches in their research endeavors.

Conclusion

John D. Scheu's contributions to the field of biomolecular imaging through his patented methods for radionuclide-labeling of biomolecules represent a significant advancement in medical technology. His work continues to influence the development of more effective imaging techniques.